Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine).
Saved in:
| Title: | Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine). |
|---|---|
| Authors: | Boyce, Ceejay L1,2 (AUTHOR), Sils, Tatiana2 (AUTHOR), Milne, Ross S2 (AUTHOR), Wallner, Jackson J2 (AUTHOR), Hardy, Samantha R2 (AUTHOR), Ko, Daisy2 (AUTHOR), Wong-On-Wing, Annie2 (AUTHOR), Mackey, Malia2 (AUTHOR), Higa, Nikki2 (AUTHOR), Beck, Ingrid A2 (AUTHOR), Styrchak, Sheila M2 (AUTHOR), DeMarrais, Patricia3 (AUTHOR), Tierney, Camlin3 (AUTHOR), Fowler, Mary G4 (AUTHOR), Frenkel, Lisa M1,2,5,6 (AUTHOR) lfrenkel@uw.edu, Team, Promoting Maternal and Infant Survival Everywhere (PROMISE) Study (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofae383 |
